Academic pharmacist Nataly Martini highlights the importance of understanding non-Hodgkin lymphoma and pharmacists’ roles in managing this condition
Old drugs give new hope in cancer
+News
In print
Old drugs give new hope in cancer
Wednesday 17 August 2022, 09:56 AM

Cancer-drug study doctor David Young with Gillies McIndoe Research Institute director Swee Tan and study coordinator Ruth Watson-Black – phase II trial is ready to launch once funding is finalised [image: Supplied]
Virginia McMillan follows up on the cancer-drug trial she first reported in 2017, when patients with glioblastoma were being recruited to test a regimen of repurposed drugs
The 17 patients in an internationally novel clinical trial run from Hutt Valley did not live to see the promising results of the drug regimen they we
References
O’Rawe M, Wickremesekera A, Pandey R et al. Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial. J Clin Neurosci 2022;95:48–54.